Cardiovascular disease remains a leading cause of morbidity and mortality in adults despite recent scientific advancements.

Higher preoperative cardiovascular risk and suboptimal postoperative ... and reviewed by a senior researcher (D.C.). LV diastolic function was evaluated after current guidelines using the following ...

American Heart Association. 2014 HRS Expert Consensus Statement on ... Expert Consensus Statement on the Perioperative Management of Patients with Implantable Defibrillators, Pacemakers and Arrhythmia ...

Pembrolizumab (Keytruda) given before and after surgery to supplement adjuvant therapy improved responses and survival in ...

The addition of neoadjuvant and adjuvant pembrolizumab to standard of care significantly improved outcomes for certain ...

Medication is as effective as CEA in reducing stroke risk in most carotid stenosis cases, new data show, suggesting some ...

When humans are trying to grasp a complicated concept or solve a problem, they might suddenly feel like they have gained a ...

Adding perioperative pembrolizumab to standard care can improve EFS in locally advanced head and neck cancer, data suggest.

Mount Sinai researchers studying a type of heart disease known as hypertrophic cardiomyopathy (HCM) have calibrated an artificial intelligence (AI) algorithm to quickly and more specifically ...

Researchers from New York City-based Mount Sinai have developed an AI algorithm to help physicians identify patients with hypertrophic cardiomyopathy by assigning a numeric probability risk ...